149 related articles for article (PubMed ID: 9855339)
1. Interaction between tacrolimus and nefazodone in a stable renal transplant recipient.
Olyaei AJ; deMattos AM; Norman DJ; Bennett WM
Pharmacotherapy; 1998; 18(6):1356-9. PubMed ID: 9855339
[TBL] [Abstract][Full Text] [Related]
2. Clinical and histological analysis of acute tacrolimus (TAC) nephrotoxicity in renal allografts.
Shimizu T; Tanabe K; Tokumoto T; Ishikawa N; Shinmura H; Oshima T; Toma H; Yamaguchi Y
Clin Transplant; 1999; 13 Suppl 1():48-53. PubMed ID: 10751057
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus toxic reaction associated with the use of nefazodone: paroxetine as an alternative agent.
Campo JV; Smith C; Perel JM
Arch Gen Psychiatry; 1998 Nov; 55(11):1050-2. PubMed ID: 9819077
[No Abstract] [Full Text] [Related]
4. Pomelo-induced increase in the blood level of tacrolimus in a renal transplant patient.
Egashira K; Fukuda E; Onga T; Yogi Y; Matsuya F; Koyabu N; Ohtani H; Sawada Y
Transplantation; 2003 Apr; 75(7):1057. PubMed ID: 12698101
[TBL] [Abstract][Full Text] [Related]
5. Potential elevation of tacrolimus trough concentrations with concomitant metronidazole therapy.
Page RL; Klem PM; Rogers C
Ann Pharmacother; 2005 Jun; 39(6):1109-13. PubMed ID: 15855244
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study of tacrolimus in postoperative treatment of patients with renal transplantation for diabetic end-stage renal disease].
Yu LX; Shan HT; Fu SJ; Du CF; Ma JJ; Xu J; Deng WF; Wang YB
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1146-8. PubMed ID: 14625173
[TBL] [Abstract][Full Text] [Related]
8. Intestinal MDR1/ABCB1 level at surgery as a risk factor of acute cellular rejection in living-donor liver transplant patients.
Masuda S; Goto M; Fukatsu S; Uesugi M; Ogura Y; Oike F; Kiuchi T; Takada Y; Tanaka K; Inui K
Clin Pharmacol Ther; 2006 Jan; 79(1):90-102. PubMed ID: 16413244
[TBL] [Abstract][Full Text] [Related]
9. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients.
Jain AK; Venkataramanan R; Shapiro R; Scantlebury VP; Potdar S; Bonham CA; Ragni M; Fung JJ
Liver Transpl; 2002 Sep; 8(9):841-5. PubMed ID: 12200788
[TBL] [Abstract][Full Text] [Related]
10. Clinically significant drug-drug interaction between tacrolimus and phenobarbital: the price we pay.
Siddiqi N; Marfo K
J Pharm Pract; 2010 Dec; 23(6):585-9. PubMed ID: 21507867
[TBL] [Abstract][Full Text] [Related]
11. Amiodarone-sirolimus/tacrolimus interaction in a pediatric heart transplant patient.
Nalli N; Stewart-Teixeira L; Dipchand AI
Pediatr Transplant; 2006 Sep; 10(6):736-9. PubMed ID: 16911499
[TBL] [Abstract][Full Text] [Related]
12. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients.
Morales JM; Andrés A; Dominguez-Gil B; Arriola M; Gutiérrez MJ; Hernández E; Ortuño T; Praga M
Transplant Proc; 2005 Nov; 37(9):3738-42. PubMed ID: 16386523
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
Waid T;
Clin Transplant; 2005 Oct; 19(5):573-80. PubMed ID: 16146546
[TBL] [Abstract][Full Text] [Related]
14. Increased early rejection rate after conversion from tacrolimus in kidney and pancreas transplantation.
Barone GW; Ketel BL; Abul-Ezz SR; Lightfoot ML
JOP; 2002 Mar; 3(2):49-53. PubMed ID: 11884766
[TBL] [Abstract][Full Text] [Related]
15. Hypotension, as consequence of the interaction between tacrolimus and mirtazapine, in a patient with renal transplant.
Fraile P; Garcia-Cosmes P; Garcia T; Corbacho L; Alvarez M; Tabernero JM
Nephrol Dial Transplant; 2009 Jun; 24(6):1999-2001. PubMed ID: 19332869
[TBL] [Abstract][Full Text] [Related]
16. Effect of coadministered HIV-protease inhibitors on tacrolimus and sirolimus blood concentrations in a kidney transplant recipient.
Barau C; Blouin P; Creput C; Taburet AM; Durrbach A; Furlan V
Fundam Clin Pharmacol; 2009 Aug; 23(4):423-5. PubMed ID: 19709321
[TBL] [Abstract][Full Text] [Related]
17. Interaction between omeprazole and tacrolimus in renal allograft recipients: a clinical-analytical study.
Pascual J; Marcén R; Orea OE; Navarro M; Alarcón MC; Ocaña J; Villafruela JJ; Burgos FJ; Ortuño J
Transplant Proc; 2005 Nov; 37(9):3752-3. PubMed ID: 16386527
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus toxicity due to drug interaction with mibefradil in a patient after liver transplantation.
Ocran KW; Plauth M; Mai I; Lochs H
Z Gastroenterol; 1999 Oct; 37(10):1025-8. PubMed ID: 10549098
[TBL] [Abstract][Full Text] [Related]
19. Acquired Pelger-Huët anomaly in association with concomitant tacrolimus and fluconazole therapy following allogeneic bone marrow transplantation.
Gondo H; Okamura C; Osaki K; Shimoda K; Asano Y; Okamura T
Bone Marrow Transplant; 2000 Dec; 26(11):1255-7. PubMed ID: 11149744
[TBL] [Abstract][Full Text] [Related]
20. Two-year follow-up study of the efficacy and safety of FK 506 in kidney transplant patients. Japanese FK 506 Study Group.
Transpl Int; 1994; 7 Suppl 1():S247-51. PubMed ID: 11271216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
